Anhui Wanbang Pharmaceutical Technology Co., Ltd.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000068J8
CNY
41.19
-0.09 (-0.22%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Net Sales
377.53
340.65
260.02
210.27
138.21
Other Operating Income
0.00
0.00
0.00
0.00
0.00
Total Operating income
377.53
340.65
260.02
210.27
138.21
Raw Material Cost
238.06
180.17
132.22
102.14
63.68
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
Employee Cost
76.74
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.03
0.02
0.02
0.02
0.01
Selling and Distribution Expenses
31.78
26.83
18.00
16.01
11.60
Other Expenses
-2.13
3.14
1.44
0.91
0.64
Total Expenditure (Excl Depreciation)
325.30
238.37
164.63
127.28
81.70
Operating Profit (PBDIT) excl Other Income
52.199999999999996
102.30000000000001
95.39999999999999
83
56.5
Other Income
32.28
12.96
14.76
10.86
6.06
Operating Profit (PBDIT)
101.08
128.28
118.48
100.05
67.07
Interest
0.03
0.02
0.02
0.02
0.01
Exceptional Items
7.03
3.77
0.00
-0.00
-0.07
Gross Profit (PBDT)
139.47
160.48
127.80
108.13
74.53
Depreciation
18.59
12.39
7.32
5.71
4.24
Profit Before Tax
89.50
119.64
111.15
94.33
62.75
Tax
3.97
11.55
12.41
12.46
8.24
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
Profit After Tax
85.53
108.09
98.73
81.87
54.52
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
Net Profit
85.53
108.09
98.73
81.87
54.52
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
85.53
108.09
98.73
81.87
54.52
Equity Capital
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
0.0
Reserves
1,513.37
1,464.01
331.62
232.88
151.01
Earnings per share (EPS)
1.28
1.62
1.48
1.23
0.82
Diluted Earnings per share
1.28
1.62
1.48
1.23
0.82
Operating Profit Margin (Excl OI)
13.3%
30.22%
37.08%
39.71%
41.08%
Gross Profit Margin
28.63%
38.76%
45.56%
47.57%
48.47%
PAT Margin
22.66%
31.73%
37.97%
38.94%
39.44%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 10.83% vs 31.00% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is -20.91% vs 9.52% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is -40.33% vs 11.19% in Dec 2023

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has fallen from Dec 2023

Compare Annual Results Of Anhui Wanbang Pharmaceutical Technology Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
377.53
0
377.53
Other Operating Income
0.00
0.00
0.00
Total Operating income
377.53
0
377.53
Raw Material Cost
238.06
0
238.06
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
76.74
0
76.74
Power Cost
0
0
0.00
Manufacturing Expenses
0.03
0
0.03
Selling and Distribution Expenses
31.78
0
31.78
Other Expenses
-2.13
0.00
-2.13
Total Expenditure (Excl Depreciation)
325.30
0
325.30
Operating Profit (PBDIT) excl Other Income
52.23
0.00
52.23
Other Income
32.28
0
32.28
Operating Profit (PBDIT)
101.08
0
101.08
Interest
0.03
0
0.03
Exceptional Items
7.03
0
7.03
Gross Profit (PBDT)
139.47
0
139.47
Depreciation
18.59
0
18.59
Profit Before Tax
89.50
0
89.50
Tax
3.97
0
3.97
Provisions and contingencies
0
0
0.00
Profit After Tax
85.53
0
85.53
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
85.53
0
85.53
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
85.53
0
85.53
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,513.37
0
1,513.37
Earnings per share (EPS)
1.28
0
1.28
Diluted Earnings per share
1.28
0
1.28
Operating Profit Margin (Excl OI)
13.30%
0%
0.00
13.30%
Gross Profit Margin
28.63%
0%
0.00
28.63%
PAT Margin
22.66%
0%
0.00
22.66%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 37.75 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 10.83% vs 31.00% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 8.55 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -20.91% vs 9.52% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 6.88 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -40.33% vs 11.19% in Dec 2023

Annual - Interest
Markets Mojo
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.30%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has fallen from Dec 2023